Adial Pharmaceuticals, Inc.
ADIL
$0.3721
$0.00010.03%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 79.90% | -52.92% | 32.66% | 1,547.45% | 169.91% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -13.26% | -4.36% | -17.06% | -12.73% | 106.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 58.98% | -50.73% | 26.89% | 394.81% | 86.79% |
|
|||||
Total Current Assets | 58.98% | -50.73% | 26.89% | 394.81% | 86.79% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -13.89% | -15.79% | -15.38% | -14.63% | -14.29% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 37.44% | -48.37% | 6.49% | 134.10% | 30.96% |
|
|||||
Total Accounts Payable | 111.90% | 218.76% | 134.22% | 288.40% | 183.53% |
Total Accrued Expenses | 52.00% | 96.91% | 28.88% | 16.48% | 3.14% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 80.24% | 135.38% | 49.43% | 56.95% | 45.50% |
|
|||||
Total Current Liabilities | 80.24% | 135.38% | 49.43% | 56.95% | 45.50% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 80.24% | 135.38% | 49.43% | 56.95% | 45.50% |
|
|||||
Common Stock & APIC | 11.91% | 6.09% | 18.09% | 23.97% | 19.18% |
Retained Earnings | -10.87% | -11.89% | -19.18% | -19.51% | -18.69% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 30.72% | -65.26% | -0.38% | 151.52% | 28.93% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 30.72% | -65.26% | -0.38% | 151.52% | 28.93% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 30.72% | -65.26% | -0.38% | 151.52% | 28.93% |
|